We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Targeting a Rare Brain Cancer With Spherical Nucleic Acids

Video   Mar 11, 2021 | Taken from NorthwesternU, YouTube

 

The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the FDA as an investigational drug for clinical investigation in the deadly brain cancer glioblastoma multiforme. 

Related coverage: 


 
 
 
Advertisement
 

Recommended Videos

Structural Biology Goes Viral With Dr Albert Konijnenberg

Video

What can integrative structural biology bring to viral research? That is the topic explored in this week's Teach Me in 10 at Technology Networks, featuring Dr Albert Konijnenberg.

WATCH NOW

The Next Generation of Vaccines and Antiviral Drugs

Video

Antiviral medicines and vaccines are both critical tools in our therapeutic arsenal for combating viral outbreaks. Discover more about vaccines and antivirals in this video from Scripps Research.

WATCH NOW

Less Is More: Why Our Brains Struggle To Subtract

Video

When solving problems, humans tend to think about adding something before they think of taking something away - even when subtracting is the better solution.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE